BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1373799)

  • 1. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
    Begleiter A; Robotham E; Leith MK
    Mol Pharmacol; 1992 Apr; 41(4):677-82. PubMed ID: 1373799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
    Begleiter A; Leith MK
    Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of quinone alkylating agents in quinone-resistant cells.
    Begleiter A; Leith MK
    Cancer Res; 1990 May; 50(10):2872-6. PubMed ID: 1692249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.
    Halinska A; Belej T; O'Brien PJ
    Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
    Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1037-41. PubMed ID: 7685584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA
    Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of trenimon-induced cytotoxicity by DT-diaphorase in isolated rat hepatocytes under aerobic versus hypoxic conditions.
    Silva JM; Rao DN; O'Brien PJ
    Cancer Res; 1992 Jun; 52(11):3015-21. PubMed ID: 1375532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
    Saeki S; Nishiyama M; Toge T
    Hiroshima J Med Sci; 1995 Sep; 44(3):55-63. PubMed ID: 8567314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase.
    Dulhanty AM; Whitmore GF
    Cancer Res; 1991 Apr; 51(7):1860-5. PubMed ID: 1900739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells.
    Baumann RP; Hodnick WF; Seow HA; Belcourt MF; Rockwell S; Sherman DH; Sartorelli AC
    Cancer Res; 2001 Nov; 61(21):7770-6. PubMed ID: 11691791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
    Sakamoto N; Toge T; Nishiyama M
    Hiroshima J Med Sci; 1997 Jun; 46(2):67-73. PubMed ID: 9232934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
    Yoshida T; Tsuda H
    Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of trenimon-induced cytotoxicity in resistant L5178Y/HBM10 cells.
    Silva JM; O'Brien PJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):639-42. PubMed ID: 1371987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.